Virax Biolabs Group Limited Gains 59.85%

Mon, Apr 13, 2026 at 07:25 PM

Virax Biolabs Group Limited (VRAX:NASDAQ) rocketted at $0.17, a gain of 59.8%. The stock appeared on our News Catalysts scanner on Tue, Mar 31, 2026 at 09:05 AM in the 'BIOTECH' category. From Mon, Mar 30, 2026, the stock recorded 33.33% Up Days and 10.00% Green Days

The stock spiked on Tue, Mar 31, 2026 at $0.28 with a volume of 238M+.

About Virax Biolabs Group Limited (VRAX:NASDAQ)

Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...

Top 10 Gainers:

Real Messenger Corporation (RMSG:NASDAQ), 475.08%
Rectitude Holdings Ltd (RECT:NASDAQ), 85.83%
RedCloud Holdings plc (RCT:NASDAQ), 77.19%
Virax Biolabs Group Limited (VRAX:NASDAQ), 59.85%
Bitcoin Depot Inc. (BTM:NASDAQ), 49.81%
DevvStream Corp. (DEVS:NASDAQ), 49.6%
Lichen International Limited (LICN:NASDAQ), 41.88%
Momentus Inc. (MNTS:NASDAQ), 41.38%
Revolution Medicines, Inc. (RVMD:NASDAQ), 41.35%
Jeffs' Brands Ltd (JFBR:NASDAQ), 40%